bf/NASDAQ:OCX_icon.jpeg

NASDAQ:OCX

OncoCyte Corporation

  • Stock

USD

Last Close

3.36

26/07 20:00

Market Cap

40.36M

Beta: 1.62

Volume Today

27.50K

Avg: 519.45K

PE Ratio

−0.42

PFCF: −0.83

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
1.22M
-
7.73M
535.44%
958K
87.60%
1.50M
56.89%
cost of revenue
344K
-
1.85M
439.24%
7.54M
306.42%
976K
87.05%
1.00M
2.66%
gross profit
-344K
-
-639K
85.76%
188K
129.42%
-18K
109.57%
501K
2,883.33%
selling and marketing expenses
2.44M
-
1.68M
31.19%
2.16M
28.73%
6.49M
200.09%
11.17M
71.96%
1.13M
89.86%
general and administrative expenses
552K
-
1.01M
83.15%
4.19M
314.54%
5.46M
30.35%
9.23M
68.99%
7.01M
24.10%
13.28M
89.54%
16.79M
26.41%
22.34M
33.05%
21.88M
2.04%
selling general and administrative expenses
552K
-
1.01M
83.15%
4.19M
314.54%
5.46M
30.35%
11.68M
113.71%
8.69M
25.58%
15.45M
77.77%
23.28M
50.74%
33.50M
43.90%
23.01M
31.31%
13.98M
39.26%
research and development expenses
2.94M
-
3.96M
34.62%
4.53M
14.26%
5.68M
25.40%
7.17M
26.37%
6.51M
9.20%
6.79M
4.30%
9.80M
44.24%
13.63M
39.09%
7.30M
46.44%
9.29M
27.30%
other expenses
-11K
-
2K
118.18%
91K
-
-3K
103.30%
27K
1,000%
-37K
237.04%
-67K
81.08%
-88K
31.34%
cost and expenses
3.50M
-
4.97M
42.29%
8.72M
75.31%
11.14M
27.78%
18.85M
69.20%
15.20M
19.35%
22.24M
46.29%
34.94M
57.10%
54.67M
56.49%
31.29M
42.77%
24.36M
22.14%
operating expenses
3.50M
-
4.97M
42.29%
8.72M
75.31%
11.14M
27.78%
18.85M
69.20%
15.20M
19.35%
22.24M
46.29%
33.08M
48.76%
47.13M
42.48%
30.31M
35.69%
23.36M
22.94%
interest expense
2K
-
19K
850%
28K
47.37%
217K
675%
216K
0.46%
299K
38.43%
-252K
184.28%
209K
182.94%
77K
63.16%
52K
32.47%
ebitda
-3.22M
-
-4.70M
46.15%
-8.72M
85.33%
-11.14M
27.81%
-18.27M
63.99%
-14.55M
20.35%
-21.69M
49.02%
-36.13M
66.61%
-16.84M
53.38%
-30.40M
80.46%
-25.78M
15.18%
operating income
-3.50M
-
-4.97M
42.29%
-8.72M
75.31%
-11.14M
27.78%
-18.85M
69.20%
-15.20M
19.35%
-22.24M
46.29%
-29.71M
33.60%
-46.95M
58.01%
-18.00M
61.66%
-22.86M
27.01%
depreciation and amortization
277K
-
281K
1.44%
283K
0.71%
387K
36.75%
580K
49.87%
559K
3.62%
553K
1.07%
-6.42M
1,260.76%
30.10M
568.94%
-12.40M
141.20%
-2.93M
76.41%
total other income expenses net
-11K
-
2K
118.18%
-28K
1,500%
-309K
1,003.57%
-336K
8.74%
-187K
44.35%
-1.48M
688.77%
-26.41M
1,690.64%
-615K
97.67%
-2.00M
224.72%
income before tax
-3.50M
-
-4.99M
42.66%
-8.73M
75.19%
-11.17M
27.85%
-19.38M
73.49%
-15.75M
18.69%
-22.43M
42.35%
-31.19M
39.06%
-73.36M
135.23%
-18.61M
74.63%
-24.86M
33.54%
income tax expense
-9K
-
-262K
2,811.11%
-387K
47.71%
217K
156.07%
-336K
254.84%
-97K
71.13%
-1.25M
1,192.78%
-9.26M
638.52%
54.83M
692.03%
2.93M
94.66%
net income
-3.50M
-
-4.99M
42.66%
-8.73M
75.19%
-11.17M
27.85%
-19.38M
73.49%
-15.75M
18.69%
-22.33M
41.74%
-29.93M
34.05%
-64.10M
114.14%
-73.44M
14.58%
-27.78M
62.17%
weighted average shs out
324.62K
-
324.62K
0%
1.05M
223.60%
1.33M
26.27%
1.51M
13.82%
1.89M
25.35%
2.56M
35.52%
3.27M
27.65%
4.45M
35.80%
5.54M
24.61%
7.65M
38.10%
weighted average shs out dil
324.62K
-
324.62K
0%
1.05M
223.60%
1.33M
26.27%
1.51M
13.82%
1.89M
25.35%
2.56M
35.52%
3.27M
27.65%
4.45M
35.80%
5.54M
24.61%
7.65M
38.10%
eps
-10.77
-
-15.36
42.62%
-8.32
45.83%
-8.42
1.20%
-12.83
52.38%
-8.32
35.15%
-8.71
4.69%
-9.14
4.94%
-14.42
57.77%
-13.26
8.04%
-3.63
72.62%
epsdiluted
-10.77
-
-15.36
42.62%
-8.32
45.83%
-8.42
1.20%
-12.83
52.38%
-8.32
35.15%
-8.71
4.69%
-9.14
4.94%
-14.42
57.77%
-13.26
8.04%
-3.63
72.62%

All numbers in USD (except ratios and percentages)